Hyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults
ALLEN R. LAST, JONATHAN D. FERENCE, ELIZABETH ROLLMANN MENZEL
Guidelines from several major organizations recommend lipid-lowering therapy for primary and secondary prevention of atherosclerotic cardiovascular disease events in at-risk patients. Multiple risk calculators are available to determine a patient's 10-year risk of an event....